Related references
Note: Only part of the references are listed.Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B
Lung-Yi Mak et al.
HEPATOLOGY INTERNATIONAL (2020)
Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders
Tikam Chand Dakal et al.
IMMUNOBIOLOGY (2020)
The serum interleukin-26 level is a potential biomarker for chronical hepatitis B
Liwen Luo et al.
MEDICINE (2020)
Incidence and Factors Associated With HBV Relapse After Cessation of Entecavir or Tenofovir in Patients With HBsAg Below 100 IU/mL
Tzu-Ning Tseng et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Combination of pegylated interferon-alpha and nucleos(t)ide analogue treatment enhances the activity of natural killer cells in nucleos(t)ide analogue experienced chronic hepatitis B patients
X. Pang et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Systematic review with meta-analysis: combination treatment of regimens based on pegylated interferon for chronic hepatitis B focusing on hepatitis B surface antigen clearance
K. Qiu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Recovery of circulating CD56dim NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg
Nianqiu Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Circulating PD-1(hi)CXCR5(+)CD4(+) T cells are associated with a decrease in hepatitis B surface antigen levels in patients with chronic hepatitis B who are receiving peginterferon-alpha therapy
Li Zhang et al.
MOLECULAR IMMUNOLOGY (2018)
HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study
Peng Hu et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2018)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment: A longitudinal observational study
Xiaoling Yang et al.
MEDICINE (2017)
Effect of switching from treatment with nucleos(t) ide analogs to pegylated interferon α-2a on virological and serological responses in chronic hepatitis B patients
Li-Ting He et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response
John Reiser et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections
Xuefen Li et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)
Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection
Chien-Hung Chen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis
Jeong Won Jang et al.
HEPATOLOGY (2015)
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Hepatitis B virus infection
Christian Trepo et al.
LANCET (2014)
Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA
Zehui Yan et al.
MOLECULAR MEDICINE REPORTS (2014)
Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B
A. K. Singal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients
Beom Kyung Kim et al.
LIVER INTERNATIONAL (2010)
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Raul Elgueta et al.
IMMUNOLOGICAL REVIEWS (2009)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
